Eli Lilly Stock: 3 High-Growth Catalysts Now
Analyzing LLY Stock highlights Eli Lilly's unshakeable dominance in the global pharmaceutical landscape. Powered by its flagship GLP-1 weight-loss and diabetes treatments-Mounjaro and Zepbound-Eli Lilly (NYSE: LLY) has evolved into…
